Topotecan Active Not Recruiting Phase 2 Trials for Neuroblastomas / Medulloblastomas Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00601003Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma